Sargent Bickham Lagudis’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$59.1K Hold
750
﹤0.01% 412
2022
Q3
$53K Sell
750
-9
-1% -$706 ﹤0.01% 399
2022
Q2
$61K Buy
759
+9
+1% +$704 0.01% 386
2022
Q1
$57K Hold
750
﹤0.01% 425
2021
Q4
$64K Hold
750
﹤0.01% 410
2021
Q3
$57K Sell
750
-504
-40% -$40K ﹤0.01% 421
2021
Q2
$102K Hold
1,254
0.01% 343
2021
Q1
$99K Hold
1,254
0.01% 336
2020
Q4
$107K Sell
1,254
-303
-19% -$25.1K 0.01% 322
2020
Q3
$120K Buy
1,557
+404
+35% +$30.8K 0.01% 272
2020
Q2
$84K Buy
1,153
+101
+10% +$7.17K 0.01% 294
2020
Q1
$70K Sell
1,052
-114
-10% -$8.04K 0.01% 293
2019
Q4
$80K Buy
1,166
+335
+40% +$22.8K 0.01% 306
2019
Q3
$61K Sell
831
-1,556
-65% -$113K 0.01% 318
2019
Q2
$171K Buy
2,387
+1
+0% +$71 0.02% 216
2019
Q1
$164K Hold
2,386
0.02% 235
2018
Q4
$142K Buy
2,386
+1
+0% +$63 0.02% 232
2018
Q3
$160K Hold
2,385
0.02% 226
2018
Q2
$155K Buy
2,385
+1
+0% +$65 0.02% 229
2018
Q1
$171K Sell
2,384
-250
-9% -$18K 0.02% 223
2017
Q4
$199K Sell
2,634
-1,094
-29% -$79.9K 0.02% 215
2017
Q3
$272K Sell
3,728
-450
-11% -$32.4K 0.03% 182
2017
Q2
$310K Sell
4,178
-205
-5% -$15.2K 0.04% 168
2017
Q1
$321K Buy
4,383
+77
+2% +$5.39K 0.04% 169
2016
Q4
$282K Buy
4,306
+1,100
+34% +$75.4K 0.04% 165
2016
Q3
$238K Sell
3,206
-100
-3% -$7.39K 0.04% 193
2016
Q2
$242K Buy
3,306
+7
+0.2% +$498 0.04% 186
2016
Q1
$233K Buy
+3,299
New +$219K 0.04% 184

Other funds holding CL

Sargent Bickham Lagudis's CL Position: Q4 2022 in Review

Sargent Bickham Lagudis held its Colgate-Palmolive (CL) position steady in Q4 2022 at 750 shares worth $59.1K. The position accounts for ﹤0.01% of the portfolio, ranked #412.

Sargent Bickham Lagudis first reported a position in CL in Q1 2016 and has held it in 28 quarters since. The position peaked at $321K in Q1 2017. 1,697 funds tracked by Wall St. Rank hold CL as of Q4 2022.

  • Sargent Bickham Lagudis held 750 shares of Colgate-Palmolive worth $59.1K as of Q4 2022.
  • Sargent Bickham Lagudis left its Colgate-Palmolive share count unchanged in Q4 2022.
  • Colgate-Palmolive made up ﹤0.01% of Sargent Bickham Lagudis's portfolio in Q4 2022, its #412 holding.
  • Sargent Bickham Lagudis first reported a position in Colgate-Palmolive in Q1 2016 and has held it in 28 quarters since.
  • Sargent Bickham Lagudis's Colgate-Palmolive position peaked at $321K in Q1 2017.
  • 1,697 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.